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We consider comparisons of statistical learning algorithms us-
ing multiple data sets, via leave-one-in cross-study validation: each
of the algorithms is trained on one data set; the resulting model is
then validated on each remaining data set. This poses two statisti-
cal challenges that need to be addressed simultaneously. The first is
the assessment of study heterogeneity, with the aim of identifying
a subset of studies within which algorithm comparisons can be reli-
ably carried out. The second is the comparison of algorithms using
the ensemble of data sets. We address both problems by integrating
clustering and model comparison. We formulate a Bayesian model for
the array of cross-study validation statistics, which defines clusters
of studies with similar properties and provides the basis for meaning-
ful algorithm comparison in the presence of study heterogeneity. We
illustrate our approach through simulations involving studies with
varying severity of systematic errors, and in the context of medical
prognosis for patients diagnosed with cancer, using high-throughput
measurements of the transcriptional activity of the tumor’s genes.
1. Introduction. Predictive models, in most cases, need to be validated
using data from independent studies. In many disciplines it is common for
research communities to generate multiple data sets that address similar
prediction problems. The availability of multiple data sets makes it possible
to systematically compare the performance of alternative statistical learning
algorithms, and to characterize their strengths and limitations in the context
of a specific area of application.
Here, the term learning algorithm is used for any procedure, say, linear
regression or nearest neighbor classification, that produces prediction rules.
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We consider the task of assessing learning algorithms, via what we call leave-
one-in cross-study validation: the algorithm is trained on one data set; the
resulting prediction model is then validated on each remaining data set, and
a validation performance statistic (such as the classification error rate or
the mean squared error of prediction) is recorded. By repeating this over
all possible training data sets one generates a square array Z of validation
statistics. Computation of leave-one-in matrices Z is, in most cases, straight-
forward. Our goal is to develop a statistical framework for the analysis of
leave-one-in matrices.
Our motivation comes from earlier experience in clinical genomics [Garrett-
Mayer et al. (2008)] where the goal is to predict individual outcomes based
on high-dimensional features of the genome. Leave-one-in cross-study vali-
dation is well suited to this context for two reasons. First, while different
studies address the same prediction question, they may do so using different
sampling designs or technological platforms, generating heterogeneity that
makes it difficult to directly combine all data. Second, it is not uncommon
for studies to be affected by unknown artifactual variation, such as the so-
called batch effects, making it important to use methodologies that allow
identification and separate handling of studies that show poor concordance
with the majority of the rest [Baggerly, Coombes and Neeley (2008)].
Our perspective is therefore that cross-study validation should simultane-
ously be concerned about two questions: the identification of heterogeneity
and outliers among studies, and the comparison of alternative algorithms,
done in a way that accounts for heterogeneity across studies. We achieve
this by modeling directly each of the algorithm-specific Z matrices. Vari-
ability in the validation measures contained in a Z matrix may arise from
several sources, including differences in study design, study populations and
measurement technologies, as well as accidental causes that may have af-
fected data quality in individual studies. To illustrate, imagine the outcome
of interest is determined by a different set of predictors in different geo-
graphical areas. A collection of studies may include two major clusters of
studies, each confined to a given area. Performance evaluations are best han-
dled by considering cross-study validation within each of these clusters, as a
good algorithm should not be required to generate models that predict well
across geographical areas when trained on data from a single area. Similar
considerations apply to clusters defined by technological platforms.
We propose a two-stage procedure. The first stage addresses sampling
variation in the Z array via Bootstrap. The second stage infers a latent par-
tition of the studies defined by a Dirichlet process. Studies will be assigned
to the same subset when the corresponding vectors of validation statistics
are similar. Conversely, if the Z array provides evidence of heterogeneity
between two studies, then these will tend to be assigned to separate clus-
ters. Our model achieves two goals: (i) to cluster studies using Z, generating
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hypotheses on the sources of heterogeneity; and (ii) to provide cluster-based
summaries of algorithm performance, allowing for comparisons that account
for heterogeneity and possible systematic artifacts in the study pool.
Clustering based on the Z matrix is perhaps most attractive in the context
of prediction problems with a large number of predictors. High dimensional-
ity makes it difficult to spot the important differences between studies and
to understand the factors hindering cross-study replicability. In this sce-
nario, it is important to provide a solid evaluation of prediction strategies
using distinct training and validation data sets. This evaluation should be
rooted in the context of a specific application. The Z matrix helps in this: its
strengths and limitations arise from reducing the problem to a single figure
of merit for prediction performance. It is simple to interpret and easy to
visualize. Also, it is not affected by subtle issues such as over-fitting, batch
effects and selection of favorable training/testing combinations. The goal of
our Bayesian procedure is to retain these advantages of the Z matrix, to
provide an accurate uncertainty analysis and to suggest clusters for further
inquiry.
While the motivation and examples for our methodology come from clin-
ical genomics, the only requirement for its application is the availability of
independent studies using similar approaches to measure predictors.
2. Bayesian cross-study validation analysis.
2.1. The leave-one-in validation performance matrix Z. We consider a
set of S studies, indexed by s and including ns samples, indexed by i. For
study s, we have measurements on outcomes Ys,i and predictors Xs,i. Our
focus is the two-dimensional array of validation statistics Z = (Zs,v; s, v =
1, . . . , S, s 6= v). We use the term algorithm to refer to a training methodology
(such as CART or ridge regression) and the term model to refer to a specific
prediction rule, resulting from using the algorithm on a training data set.
For a given algorithm, the statistic Zs,v measures the predictive performance
of the model trained on data set s, when validated on a different data set
v. Typical definitions of Zs,v with binary outcomes include the classification
error rate and, if the model generates risk scores for binary outcomes, the
area under the operating characteristic curve (AUC). Validation statistics
for time-to-event outcomes include versions of the concordance index [Uno
et al. (2011) and references therein]. Our approach is based on the Z matrix
and does not include direct modeling of the data at the individual level.
This choice is motivated by the goal of obtaining easily interpretable results
with modest computational effort.
In addition to Zs,v, with s 6= v, one can also consider the variables Zs,s,
obtained by standard cross-validation, iteratively splitting the data set into
training and validation components. Here we do not use the variables Zs,s
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to avoid summary statistics that might be inflated by systematic errors or
batch effects.
2.2. Relation to Bayesian meta-analysis. There are important points of
contact, as well as differences, between our approach and existing ideas in
Bayesian meta-analysis.
Bayesian modeling allows one to easily account for study heterogeneity.
Several approaches are based on hierarchical models [Berry (1990)]. For ex-
ample, Warn, Thompson and Spiegelhalter (2002) consider S = 31 random-
ized trials for assessing the analgesic Ibuprofen. The data for each study
consist of sample size, number of individuals randomized to placebo and
number of events (pain relief) for each arm. Treatment assignments Xs,i
and outcomes Ys,i are binary. They specify a hierarchical model with latent
parameters θs describing success rates in each study and an unknown dis-
tribution F describing variability in the study specific parameters, that is,
θs|F i.i.d.∼ F . The assumption that, conditionally on these parameters, indi-
vidual observations within each study are independent completes the model.
Heterogeneity of study-specific parameters is often better understood via
clustering, as we will propose here. Berry and Christensen (1979) introduced
the idea of using a Dirichlet prior for F . A practical advantage of the Dirich-
let process in this context is the resulting discreteness of F . This implies that
when (θ1, . . . , θS) are sampled either from the prior or from the posterior,
one observes clusters of studies: for every pair (s, v) the event θs = θv has
positive probability. Thus, one obtains a posteriori the distribution of a la-
tent random partition of the studies {1, . . . , S} dictated by ties in the values
of the parameters (θ1, . . . , θS). While evidence synthesis may average over
the distribution of this partition, cluster analysis can be performed by se-
lecting a single representative partition. Model-based clustering and the use
of a latent partition are effective for dealing with questions and hypotheses
such as (i) the response probabilities are the same across studies, (ii) there
exists a large group of studies sharing identical response probabilities and
(iii) there are studies that should be considered outliers.
2.3. Two-stage analysis. Our validation analysis uses a summary of the
data, consisting of (i) the Z array and (ii) a parametric estimate dˆ of the
unknown joint distribution d of the zero mean random variables Zs,v − ζs,v,
where s, v = 1, . . . , S, s 6= v, and ζs,v is the expected value of Zs,v. The ex-
pected values ζs,v = EPs,Pv(Zs,v) refer to the true unknown distributions of
the data Ps and Pv within studies s and v. These are joint distributions
including both predictors and outcomes, and might vary across studies.
Our approach is in two stages. The first stage estimates the dispersion of
the Zs,v random variables. The second stage is based on a Bayesian model,
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specified using a Dirichlet prior and the dispersion of the Z’s estimated in
the first stage.
We propose a simple hierarchical model for Z that balances (i) the need,
as in any validation study, of easily interpretable summary statistics that
are free of questionable assumptions and (ii) the goal of detecting clusters
of studies and possible outliers. We chose a prior model for Z with a mini-
mal level of complexity in order to avoid difficulties in the interpretation of
the resulting estimates. Similar to Bayesian meta-analysis, we use latent pa-
rameters for the unknown means of our Z random variables. The posterior
distribution of these parameters, as discussed in Section 3, allows clustering
of the studies. The goal of the model is to cluster studies with similar data
quality, as well as studies sharing similarities in their designs and imple-
mentations. We will first provide a description of our model and clustering
approach in Section 3, assuming identical sample sizes n1 = · · ·= nS across
studies, and then remove this constraint.
One of the advantages of modeling the Z array is the possibility of esti-
mating, for any pair of studies (s, v), the distribution of Zs,v should both
studies be performed a second time. Estimates can be derived using the hy-
pothesis that data are newly generated under identical technical conditions
and that the populations from which samples arise remain identical. When
the estimates of ζs,v are combined with the inferred partition of the studies
{1, . . . , S}, these contribute to interpretation of the observed values in our
Z array.
Stage 1. The first stage estimates d, with the goal of obtaining an ap-
proximate Bayesian analysis for the observed Z array. The approximation
consists of plugging an estimate of d into the Bayesian model (Stage 2) to
bypass computationally intensive joint modeling of S data sets. A practical
method is the Bootstrap, either in its frequentist [Efron (1979)] or Bayesian
[Rubin (1981)] versions. The resulting distribution is representative of the
sampling variability of the Z statistics. The observed variations across the
Z’s are due to both sampling variability and also to possible differences
across the study-specific distributions P1, . . . , PS .
The only result from the first stage of our procedure that we use in the
analysis of the leave-one-in array is the estimate dˆ. Alternative estimators
of d could in principle be used. Here we use the bootstrap because of its
broad applicability. It can be applied to Z matrices generated by a spectrum
of training methods ranging from popular machine learning procedures to
algorithms highly tailored to specific application areas. Also, the bootstrap
can estimate the variability of a number of possible validation summaries,
such as the misclassification error rate or the mean squared error, that can
be used to define Z arrays. Finally, the bootstrap is applicable wether or
not there exists a probability model consistent with the training algorithm.
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The Bootstrap [Efron (1979)] for estimating d includes (i) the compu-
tation of the empirical distributions Pˆ1, . . . , PˆS , which (ii) are then itera-
tively used for obtaining S independent Bootstrap samples, one for each
study, (X∗1,i, Y
∗
1,i; i ≤ n1), . . . , (X∗S,i, Y ∗S,i; i ≤ nS), with (X∗s,i, Y ∗s,i) ∼ Pˆs. Here
we avoid the use of an additional index enumerating Bootstrap iterations.
At each iteration the validation statistics are computed on the basis of
(X∗1,i, Y
∗
1,i; i≤ n1), . . . , (X∗S,i, Y ∗S,i; i ≤ nS), that is, the Z array is resampled.
At each cycle we compute a prediction model using (X∗s,i, Y
∗
s,i; i ≤ ns) and
then validate it on (X∗v,i, Y
∗
v,i; i ≤ nv), s 6= v, to obtain Z∗s,v. Finally, (iii)
we estimate d by centering the empirical distribution of the iteratively re-
sampled arrays. The Bootstrap estimate of d, as the number of iterations
increases, converges to the nonparametric maximum likelihood estimate of
d. In other words, by resampling we approximate the mapping of Pˆ1, . . . , PˆS
to the distribution of (Zs,v− ζs,v; s, v = 1, . . . , S, s 6= v) under the assumption
that Ps = Pˆs for every s≤ S.
When d is estimated by the Bayesian Bootstrap, the flow of the pro-
cedure remains identical, with the exception that the initial components
Pˆ1, . . . , PˆS are replaced by random distributions P
∗
1 , . . . , P
∗
S . The random dis-
tributions P ∗1 , . . . , P
∗
S are defined by P
∗
s ∝
∑
i≤ns
Ws,iI(Xs,i,Ys,i), where Ws,i,
i≤ ns, are independent exponential variables with a fixed scale parameter.
The Bayesian Bootstrap averages over iteratively generated random distri-
butions P ∗1 , . . . , P
∗
S . In this case, the resampling scheme allows us to obtain
the Bayesian estimate of the Z’s dispersion under Dirichlet process priors
with infinitesimal concentration parameters for P1, . . . , Ps.
Stage 2. We specify a Bayesian model for the validation statistics Z. To
simplify posterior computations, we plug in a zero mean multivariate normal
distribution dˆ into our model by matching the covariance matrix estimate
from the Bootstrap algorithm in the previous paragraph. This choice, in
several cases, is justified by convergence of the actual joint distribution of
the validation statistics Z, for large sample sizes, to a Normal density. We
will provide examples of such convergence.
We introduce an exchangeable random partition Π = {C1, . . . ,Cm} of
{1, . . . , S}, where Cj , j = 1, . . . ,m are groups of studies. The number of
clusters m is a random variable. The random partition Π of {1, . . . , S} is
specified by S exchangeable variables sampled from a discrete random dis-
tribution; the Dirichlet process is an example. We refer to Lee et al. (2013)
for an overview on exchangeable partitions. We use C(s) for indicating the
subset of the partition Π that includes study s. Also, we use pΠ to denote
the law of the random partition. We state the probability model for Z; it
includes a latent partition and a set of random variables (µi,j; i, j = 1, . . .)
which play a role similar to the atom locations in a Dirichlet process mixture:
µ= (µi,j; i, j = 1, . . .)
i.i.d.∼ pµ,
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Π∼ pΠ,
(2.1)
ε= (εs,v; s, v= 1, . . . , S, s 6= v)∼ dˆ and
Zs,v = µC(s),C(v) + εs,v, s, v= 1, . . . , S, s 6= v,
where the components µ,Π and ε are a priori independent and pµ is a
distribution on the real line.
The probability that the conditional expected values of a pair (s, v) of Z
columns (or rows) are identical is strictly positive:
p
(⋂
r≤S
{µC(s),C(r) = µC(v),C(r), µC(r),C(s) = µC(r),C(v)}
)
> 0.
Also, the distribution of the array (µC(s),C(v); s, v = 1, . . . , S, s 6= v) is invari-
ant with respect to any permutation σ = (σ1, . . . , σS) of {1, . . . , S},
(µC(s),C(v); s, v = 1, . . . , S)
d
=(µC(σs),C(σv); s, v= 1, . . . , S).
The model can handle an arbitrary number of additional studies (S +
1, S+2, . . .). Therefore, one can perform predictive inference by considering a
future (S+1)th study and obtain, conditionally on the observed Z statistics,
the distribution of (µC(S+1),C(s), µC(s),C(S+1); s= 1, . . . , S).
Arrays with exchangeable rows and columns have been studied in a series
of papers beginning with the contributions of Aldous (1981) and Hoover
(1982). These authors proved de Finetti-type representations for these pro-
cesses. Random arrays invariant in distribution to any simultaneous permu-
tation σ of rows and columns, such as (µC(s),C(v); s, v ≥ 1), are called jointly
exchangeable. This type of arrays arises, for instance, when relationships be-
tween individuals are represented using two-way tables [Roy and Teh (2009)].
In our study, these representation theorems provide a formal justification to
use latent cluster membership variables for modeling exchangeable arrays.
2.4. Asymptotic normality of validation arrays. The proposed model for
Z is closely connected with Dirichlet process mixtures. Consider, for ex-
ample, S studies designed for estimating θs = E(Ys,i). A possible approach
for exploring the hypothesis of multiple clusters defined by studies with
identical means θs consists in combining approximate likelihood functions
N(Y¯s =
∑
i Ys,i/ns; θs, σˆ
2
s/
√
ns) with a random distribution F for the means,
that is, θs|F i.i.d.∼ F . See Burr and Doss (2005) for a detailed study of this ap-
proach, and Dersimonian and Laird (1986) for a frequentist perspective. The
approximation, from a Bayesian standpoint, consists in using Normal kernels
with scale parameters
√∑
i(Ys,i − Y¯s)2/ns, and is supported by asymptotic
arguments. Similarly, we combine an exchangeable random partition with
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a multivariate Normal kernel dˆ justified, in several cases, by asymptotic
arguments.
A smooth estimate of d is computationally convenient and circumvents
artifacts that arise with a discrete one, including the possibility of poste-
rior distributions assigning exactly null probability to most of the Π config-
urations. One can identify several cases in which the leave-one-in array is
asymptotically Normal. Below we briefly discuss one case where Z converges
to a multivariate Normal distribution on a linear subspace of RS×(S−1). We
discuss results for logistic regression, Poisson regression, proportional haz-
ards models and support vector machine procedures in the supplementary
material [Trippa et al. (2015)].
Consider the linear model Ys|Xs ∼N(Xsβs, Iσ2s), with (Ys,Xs) = (Ys,i,Xs,i;
i≤ ns), least squares estimates βˆs and mean squared errors (MSE) of pre-
diction
Zs,v =
‖Yv −Xvβˆs‖2
nv
.
Here, and in all the examples in the Supplementary Material, we let all sam-
ple sizes grow at the same rate, ns ≈ csn1, s = 2, . . . , S, and fix c2, . . . , cS .
Independence of ‖Yv −Xvβˆv‖2 and (Xv, βˆv) implies, under mild assump-
tions on the Xs,i distributions, asymptotic normality. First, n
−1/2
v (‖Yv −
Xvβˆv‖2−nvσ2v)→N(0,2σ2v). Next, to obtain Zs,v, we need to add to the in-
sample mean squared error n−1v ‖Yv −Xvβˆv‖2 a second term, n−1v [‖Xv(βv −
βs)‖2+2(δv−δs)XvXv(βv−βs)+‖Xv(δv−δs)‖2], with δv = (βˆv−βv). It can
be shown that n
−1/2
v (δv − δs)[XvXv(βv − βs)− E(XvXv(βv − βs))]→ 0 and
n
−1/2
v (δv − δs)XvXv(δv − δs)→ 0. Finally, both n−1/2v (δv − δs)E(XvXv(βv −
βs)) and n
−1/2
v (βv−βs)(XvXv−E(XvXv))(βv−βs) converge to normal den-
sities. Asymptotic joint normality for Z follows from the asymptotic inde-
pendence of δv and n
−1/2
v (XvXv).
3. Cluster-based validation statistics. The procedure we propose gen-
erates a posterior distribution p(Π|Z) for the unknown partition Π of our
S studies. The tuning of the distribution pΠ and approaches for selecting
the prior model are discussed in the supplementary material [Trippa et al.
(2015)]. A representative partition summarizes the posterior distribution.
We select an estimate Πˆ that minimizes the expectation of a loss function
l(Πˆ,Π), that is, Πˆ = argminE(l(·,Π)|Z). The partition Πˆ is a posterior point
estimate. Quintana and Iglesias (2003) give a discussion on the decision the-
oretic paradigm applied to random partitions. Several loss functions l(Πˆ,Π)
have been proposed; see, for example, Denœud and Gue´noche (2006).
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We use the easily interpretable maximum transfer metric; see Charon
et al. (2006) for a recent contribution. This metric l(Π1,Π2) is defined
as the minimum number of elementary corrections necessary to match the
partitions Π1 and Π2; an elementary correction consists of moving a unit
to a different (possibly empty) subset. If we consider, for example, Π1 =
({1,2},{3,4}) and Π2 = ({1,4},{2,3}), then l(Π1,Π2) = 2, and a possible
chain of corrections is ({1,2},{3,4})→ ({1,2,3},{4})→ ({1,3},{2,4}).
Our procedure tends to assign studies to separate clusters when they differ
on aspects that affect the validation statistics Z. The dissimilarity captured
by the clustering method might be due to different measurement techniques,
different predictors distributions or other factors varying across studies. In-
terpretation of the inferred partition requires subsequent analyses to identify
the primary causes of heterogeneity, such as data quality or experimental
designs. The results can then inform the construction of models trained on
multiple data sets. If, for instance, heterogeneity is driven by different dis-
tributions of relevant predictors, but the covariates effects on the outcome
are consistent across studies, then it might be appropriate to combine the
available data sets. In contrast, if heterogeneity is driven by measurement
errors or batch effects, additional efforts may focus on data normalization
steps.
We can now introduce the concept of clustering-based validation perfor-
mance measure, by which we mean summary statistics aimed at assessing
cross-study prediction taking into account study heterogeneity and within-
cluster similarities. Recall that model 2.1 formalizes the identity between
the conditional expected values of Zs,v and Zs′,v′ when study s clusters to-
gether with s′ and v clusters with v′. For example, we may be interested
in the performance measure obtained when one trains on any of the studies
in the cluster of study s and validates in any of the studies in the cluster
of study v, that is, µC(s),C(v). The latent variable C(s) indicates the clus-
ter that includes s and µC(s),C(v) can be interpreted as the expectation of
Zs,v assuming that studies s and v are repeated de novo. A point estimate
E(µC(s),C(v)|Z) can be obtained by averaging E(µC(s),C(v)|Π,Z) with respect
to the posterior distribution of the partition Π. Similarly, one may derive
interval estimates.
We can also estimate the validation performance that one would ob-
tain from training in a study from the set C(s), and validating in a future
(S +1)th study, by using µC(s),C(S+1). In particular, the joint posterior dis-
tribution of µC(s),C(S+1) and µC(v),C(S+1), with s, v ≤ S, can be used for
comparing studies s and v.
Let B be a subset of studies in {1, . . . , S}. We extend the definition of the
validation statistic Zs,v to handle the case where a model is trained on the
combination of the data from all the studies in B, and then validated on
study v. We denote the resulting validation statistic by ZB,v . If B includes
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v, then v is not used to train the model, and ZB,v is redefined to be the
same as ZB\v,v , where B \ v = {s≤ S : s ∈B and s 6= v}. We also use B(s)⊂
{1, . . . , S} to denote the studies within the same Π latent cluster of s, that
is, B(s) = {v ≤ S :C(s) =C(v)}.
Clustering has the goal of identifying homogeneous groups of studies with
similar sampling distributions. When this works, it is natural to train models
by combining the studies in a cluster. However, the figure of merit used for
the Z summary, not unlike a loss function, implies adopting a specific one-
dimensional perspective in looking at the data. It is possible, for example,
that two studies with different covariate distributions might be clustered to-
gether, or two studies which only differ in design, but not in the populations,
may be allocated to separate clusters.
Clustering can be used to estimate the performance obtained when val-
idating in study s after training on studies in B(s), that is, using only
data sets similar to s. This task reduces to estimating ZB(s),s. The function
B → ZB,s, over the collection of {1, . . . , S} subsets, can be directly com-
puted using our S data sets and is not related with the Bayesian model,
but ZB(s),s, the value of this function at B(s), is estimated because B(s) is
an unknown latent component of the model. This approach is only useful
when there is no strong evidence that s belongs to a singleton cluster. We
thus estimate ZB(s),s by using the posterior distribution of the partition Π
and conditioning on the event B(s) 6= {s}. We report both the estimate of
ZB(s),s obtained by averaging over Π configurations with B(s) 6= {s} and the
posterior probability of the conditioning event B(s) 6= {s}. Alternatively, we
can generate a plug-in estimate ZBˆ(s),s by focusing on Bˆ(s), the cluster in
Πˆ that includes the sth study.
When we estimate ZB(s),s the goal is to evaluate a model trained by a
homogeneous set of studies B(s). Our clustering procedure uses validation
statistics to detect study heterogeneity, and therefore the resulting partition
is representative of differences between studies captured by the Z valida-
tion summaries. Studies included in the same cluster could still differ in
important ways. We consider this point further in the discussion.
For comparing studies, we also need to be concerned about the poten-
tial for variations of clustering-based summaries, such as ZB(s),s, driven by
different total sample sizes within each cluster. Under the assumption of
identical sample sizes n1 = · · · = nS , which will be later removed, one can
expect that the value ZB(s),s improves with the number of studies in B(s).
We thus define the sample size adjusted validation statistics ZjB,s. The defi-
nition of these statistics is analogous to that of ZB,s. We randomly select j
distinct samples from the ensemble of studies B. We train a model on these
j samples and validate it on data set s to generate a performance measure,
say, an AUC. We iterate this procedure, keeping fixed both B and s; ZjB,s
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is the average of the accuracy measures obtained during these iterations. In
this case, if B includes s, then the units in s are not selected for training
the model. The index j can vary from a minimal size of interest up to the
overall number of samples in B \ s.
Our interest is in the map j→ ZjB(s),s; recall that B(s) is unknown but
can be estimated using the posterior distribution of Π. The statistics ZjB(s),s
have an interpretation similar to ZB(s),s; moreover, one can contrast the
estimates of ZjB(s),s and Z
j
B(v),v to compare the sth study to the vth study.
We can estimate ZjB(s),s plugging in the point estimate Πˆ or directly using
the posterior distribution of Π. If we follow the first approach, the estimator
is Zj
Bˆ(s),s
, while the second approach averages with respect to the posterior
distribution of B(s). In both cases we estimate, assuming
∑
B(s) nv ≥ j+ns,
the mean value of the validation statistic when the algorithm is trained by
j data points from the unknown subset B(s) \ s and then validated on s.
In the second case, we report the posterior probability of
∑
B(s) nv ≥ j+ns,
and compute our estimate conditionally on this event because ZjB(s),s is well
defined only when B(s) includes at least j + ns units.
4. Simulation study.
4.1. Scenario 1. The goal of this simulation study is to illustrate the
extent to which our model-based approach contributes to the interpretation
of cross-study validation statistics, beyond what can be learned from direct
visualization of Z. As this relies on estimating the unknown partition Π
and the latent µC(s),C(v) variables, we also discuss our model’s ability to
reconstruct these.
The scenario is defined by 9 studies grouped into three clusters, C1 =
{1,2,3}, C2 = {4,5,6} and C3 = {7,8,9}, which differ in the amount of mea-
surement error in the predictors. All studies have a sample size of 300. For
subject i from study s we have a binary outcome Ys,i and 50 candidate
predictor variables Xs,i. In group C1, the 50 covariates are simulated from
a multivariate Normal distribution with null mean; all variances are equal
to 17. The dependence between Xs,i and Ys,i, s = 1,2,3, is specified by a
logistic regression function; 10 regression coefficients are equal to 0.1 and 40
are equal to 0. In group C2 we add independent measurement errors with
null mean and standard deviation equal to 14 to 50% of the covariates. In
C3 we add independent measurement errors with mean 0.33 and standard
deviation 8 to all covariates.
For each study we obtain a prediction model by fitting a logistic function
using ridge regression; we tune the penalization parameter with standard
cross-validation. We then assess model performance using the mean abso-
lute error (MAE) of prediction, that is, Zs,v = n
−1
v
∑
i ‖Yv,i − logit−1(βˆos +
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βˆsXv,i)‖, where (βˆos , βˆs) denote the regression coefficients estimated using
only data from study s.
Figure 1(A) shows the Z array for a single simulation, with rows cor-
responding to training data sets and columns corresponding to validation
data sets. This array shows that sampling variability accounts for a rele-
vant part of the observed differences across validation summaries, and the
resulting panel is not easily interpretable by direct visual inspection. Fig-
ure 1(B) shows Monte Carlo approximations of the true expected values
ζs,v of the Zs,v variables under the described sampling models. The ex-
pected value ζs,v is computed integrating with respect to the actual distri-
butions (Ps, Pv) of (Xs,i, Ys,i) and (Xv,i, Yv,i). Figure 1(C) shows the cluster-
Fig. 1. Leave-one-in array, with rows corresponding to training data sets and columns
to validation data sets. Panel (A) shows the leave-one-in array Z for a single simulation.
Panel (B) shows the true expected values ζs,v of Zs,v. Panel (C) shows the Bayesian es-
timates E(µC(s),C(v)|Z). The diagonals in panels (A), (B) and (C) are blank. Panel (D)
considers 500 simulations and plots the empirical estimates Zs,v against the Bayesian es-
timates E(µC(s),C(v)|Z). Panel (D) considers a training data set s in C1 and a validation
data set v in C2. The green lines correspond to the true expected value ζs,v. Panel (D)
also reports the MSE ratio contrasting the Bayesian estimates with the empirical esti-
mates. Panel (E) contrasts the Bayesian estimates of ζs,v with the empirical estimates by
displaying the MAEs. Panel (E) considers all combinations with s and v in C1,C2 or C3.
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based Bayesian estimates E(µC(s),C(v)|Z) based on our two-stage procedure.
In this simulation, our clustering procedure gives a point estimate Πˆ =
[{1},{2,3},{4,5,6},{7,8,9}] of the latent partition. The distance l(Πˆ,ΠTRUE),
measured with the maximum transfer metric, is equal to 1.
Comparison of panels (A) and (C) shows that the two-stage procedure
correctly reconstructs the block structure of the true expected values ζs,v dis-
played in panel (B). Also, the procedure correctly identifies a group of stud-
ies, which are not affected by measurement errors, with estimated µC(s),C(s)
value below 0.2.
We repeated the simulation 500 times. In each iteration, and for each pair
(s, v), we estimated the unknown ζs,v means using our Bayesian estimator
E(µC(s),C(v)|Z) and the empirical estimator Zs,v. The results are plotted in
Figure 1(D) against each other for a single (s, v) combination, with s in C1
and v in C2. Then, for each (s, v) combination, we contrasted the MSEs and
the MAEs of the Bayesian estimates with the empirical estimates. Across all
(s, v) combinations the Bayesian estimator has lower MSE and MAE than
the empirical estimates. These results are graphed in panel (E); each point
corresponds to one (s, v) combination, and the MAEs of the Bayesian and
empirical estimates are plotted against each other. In this comparison the
Bayesian estimator achieves a substantially lower dispersion around the true
expected value ζs,v compared to the empirical estimator.
For each simulation we computed l(Πˆ,ΠTRUE), the number of elementary
set operations between the true and estimated latent partition. On aver-
age this distance is 1.63 and, in most iterations, Πˆ has a distance of 2 set
operations or less from Π.
4.2. Scenario 2. We consider a sampling model previously used in Wal-
dron et al. (2011). We use it to investigate how the comparison of alternative
algorithms is enhanced by Bayesian modeling of the Z arrays. Here we add
measurement errors to the outcome variable in subsets of studies. We in-
vestigate how modeling of Z allows algorithm performance assessment for
continuously varying training sample size. The main focus is on the maps
j→ ZjB(s),s to contrast methods. We also highlight how posterior inference
on clustering based statistics, such as the estimates of µC(s),C(v), captures
uncertainty on the algorithms’ performances.
We simulated 540 zero-mean Normal predictors Xs,i with a covariance
matrix structured in blocks:
σl,j =


1, if l= j,
0.2, if l, j ≤ 100 and l 6= j,
0.2, if 100< l, j ≤ 200 and l 6= j,
0.2, if 200< l, j ≤ 370 and l 6= j,
0, otherwise.
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Conditionally on these predictors, we then generated binary outcomes Ys,i
with E(Ys,i|Xs,i) = [1 + exp(−βXs,i)]−1. Here i≤ ns = 100 and s= 1, . . . ,9.
The regression coefficients (β1, . . . , β540) are βj = 0.2 for j ≤ 370 and βj = 0
for j > 370. Departing from the sampling model of Waldron et al. (2011),
we added measurement errors to Ys,i, by changing the value of Ys,i with
probability 0.05 in C1 = {1,2,3}, 0.25 in C2 = {4,5,6} and 0.5 in C3 =
{7,8,9}. These probabilities are independent of Ys and Xs. Note that any
classification approach applied to studies s= 7,8,9 has an average error rate
of 0.5 because the binary outcomes Ys,i, after measurement errors, become
independent from the covariates and E(Ys,i|Xs,i) = 0.5.
We consider for illustration three classification methods: LASSO regres-
sion, ridge regression and a linear support vector machine; penalization pa-
rameters are tuned with cross-validation. We choose our validation statistics
to be the classification error rates. For each study s, we computed the true
clustering-based ZjB(s),s statistics; in simulation studies the true latent par-
tition, as well as B(s), s = 1, . . . , S, is known. If, for instance, s = 1, then
B(s)\s= {2,3}, and ZjB(s),s measures the average classification performance
obtained when a model is trained by j ≤ 200 records randomly sampled from
B(s) \ s. The classification performance is obtained through empirical vali-
dation on data set s.
We then used the posterior distribution of B(s) \ s and computed the
estimates E(ZjB(s),s|Z,
∑
v∈B(s)\s nv ≥ j). The first three panels in Figure 2
contrast ZjB(s),s (dashed lines) with the Bayesian estimates (solid lines); each
color corresponds to one of the three methods. Overall, the estimates cor-
rectly portray the differences that exist between the performances of the
three algorithms; in this scenario, the support vector machine slightly out-
performs ridge regression, which, in turn, has lower prediction errors than
LASSO. These differences are shown in the third row of Figure 2 where
we plot the maps j → ζjs , with ζjs equal to the expected value of ZjB(s),s.
The second line of panels in Figure 2 shows the posterior probabilities
p(C(s) = C(v)|Z). In this example, the proposed model captures the un-
derlying partition of the 9 studies and the differences across methods’ per-
formances.
We repeated the simulation 500 times, generating 9 independent data sets
for each iteration. In the bottom three panels of Figure 2, we show medians
and quartiles of the ZjB(s),s posterior estimates, for j = 100,200, obtained
across these 500 iterations. These are compared to approximations of the
true maps j→ ζjs , obtained by averaging the true error rates ZjB(s),s across
simulations. These maps are displayed with solid lines in the third row of
panels in Figure 2. These panels summarize the distribution across simu-
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Fig. 2. Clustering based validation statistics. The top row considers a single simulation
and compares the true values of the validation statistics Zj
B(s),s (dashed lines) with our
Bayesian estimates (solid lines) for varying size of training sets. Using the same data,
the second row displays the posterior probabilities that two studies, s and v, are clustered
together. The third row summarizes results from 500 simulations; solid lines display the
true expected values ζjs of Z
j
B(s),s
, while dots marks medians and quartiles of the corre-
sponding Bayesian estimates at j = 100 and j = 200 across simulations. Colors denote the
three algorithms. In the 1st (2nd, 3rd) column s= 1 (4,7).
lations of the estimated clustering validation measures ZjB(s),s and confirm
that the estimates are representative of the performances of the algorithms
being compared.
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Table 1
The nine ovarian cancer data sets considered in this study. We only considered late-stage
serous tumors from these studies
s Study ns Microarray platform
1 Bentink et al. (2012) 117 Illumina Human v2
2 Crijns et al. (2009) 157 Operon Human v3
3 Yoshihara et al. (2010) 110 Affymetrix hgug4112a
4 Bonome et al. (2008) 185 Affymetrix hgu133a
5 Tothill et al. (2008) 139 Affymetrix hgu133plus2
6 The Cancer Genome Atlas Research Network (2011) 420 Affymetrix hthgu133a
7 Mok et al. (2009) 53 Affymetrix hgu133plus2
8 Konstantinopoulos et al. (2010) 42 Affymetrix hgu95av2
9 Dressman et al. (2007) 59 Affymetrix hgu133a
5. Application to survival prediction in cancer. We illustrate an applica-
tion to the development of a prediction model for overall survival of ovarian
cancer patients using microarray gene expression data. Ovarian cancer is
the most lethal gynecological cancer, and numerous groups have undertaken
microarray experiments to measure tumor gene expression for development
of prognostic models of patient survival. It is widely accepted that gene sig-
natures proposed for clinical application must be validated on independent
data sets. In this area of research several strategies and methods have been
proposed for prediction. Which one works best? How much uncertainty is in-
volved in ranking methods? Posterior probabilities on the µC(s),C(v) random
variables are suitable for answering these questions.
We identified nine previously curated studies utilizing five different mi-
croarray platforms, each providing patient overall survival for at least 40
late-stage, serous-type, ovarian tumors (Table 1). Microarray data were pro-
cessed using standard normalization methods, after which probe identifiers
were mapped to standard gene symbols, as provided by the curatedOvar-
ianData library [Ganzfried et al. (2013)]. Only gene symbols represented on
all platforms were considered for across-platform comparability. We noted
that limiting consideration to those genes present across all platforms has
a negligible effect on prediction performance. For example, we separately
fitted Cox models with ridge penalty and estimated with cross-validation C-
statistics, separately considering one study at a time; the average decrease
of the C-statistics when only genes present in all platform were considered
compared to using all available genes was less than 0.01.
5.1. Accounting for different sample sizes. The sample size ns varies
across studies. One can therefore expect higher values of the validation
statistics Zs,v for those models trained in the largest studies. To prevent
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this from creating artifactual clusters of studies, we apply an intuitive cor-
rection.
We selected a threshold of 110 samples and considered the 6 studies that
have a sample size larger than the threshold. We then computed the em-
pirical estimates Z110 = (Z110s,v ; s, v = 1,2,3,4,5,6, s 6= v). The computation
of Z110s,v is straightforward. We iterate two steps: (i) we train a prediction
model M110s with 110 data points sampled without replacement from the
sth data set, then (ii) we validate the resulting model on the entire vth data
set. We set Z110s,v equal to the average value of the validation statistics across
iterations. The statistic Z110s,v estimates the performance of a model trained
by 110 samples from Ps. We computed these estimates with 200 iterations.
The covariance matrix Σ110 of Z110 is then estimated by bootstrapping.
The array Z110 and Σˆ110 are used for obtaining the posterior distribution of
the random partition Π110 with the model proposed in Section 2; we only
replace (Z,Π) with (Z110,Π110). The reported probability that two studies,
say, s= 1 and v = 6, belong to the same cluster is provided by the posterior
distribution p(Π110|Z110, Σˆ110).
Next, we need to extend this posterior, which refers to the 6 studies we
selected, to the remaining 3 which have less than 110 samples. To achieve
this goal, we compute p(Π42|Z42, Σˆ42) by reducing the threshold from 110
to 42, and report the following adjusted random partition:
pˆ(Π = pi) =
p(Π42 = pi|Z42, Σˆ42)× p(Π110 =∆110(pi)|Z110, Σˆ110)∑
pi′ 1(∆
110(pi′) = ∆110(pi))p(Π42 = pi′|Z42, Σˆ42) ,(5.1)
where the sum is over possible partitions of the 9 studies and the operator
∆110 projects them into partitions of the 6 studies {1,2,3,4,5,6} above the
110 samples threshold. Two of these 6 studies (s, v) are clustered together
by pi if and only if they are clustered together by ∆110(pi). Expression (5.1)
implies pˆ(∆110(Π) = ·) = p(Π110 = ·|Z110, Σˆ110).
This correction for sample size effects preserves the interpretability of
the clustering algorithm. It also avoids more complex constructions, such as
replacing the latent random variables µ in (2.1) with latent functions for
sample size-specific average validation statistics. The most computationally
intensive stage of the procedure is the computation of Σ42 and Σ110; the
arrays Z42 and Z110 have been resampled 1000 times.
5.2. Comparative analysis of prediction methods. Ovarian cancer stud-
ies for developing prognostic signatures are commonly based on two dis-
tinct groups of data sets, a training group, which in most cases only in-
cludes a single data set, and a group of publicly available validation data
sets. A recent example that presents key questions related with our study is
Kang, D’Andrea and Kozono (2012), and the subsequent comment Swisher,
18 TRIPPA, WALDRON, HUTTENHOWER AND PARMIGIANI
Taniguchi and Karlan (2012). The goal in Kang, D’Andrea and Kozono
(2012) is to develop a molecular score based on expression of 151 genes that
are involved in platinum-induced DNA damage repair to predict response
to chemotherapy. This exemplifies using a biological hypothesis to preselect
predictors for constructing prognostic models, thus avoiding some of the
challenges arising in the “large p small n” setting. In Swisher, Taniguchi
and Karlan (2012) authors point out that both independent validations and
a suitable sample size of the validation data set are essential for assessing
prediction models.
Prescreening the space of predictors has the advantages of parsimony and
interpretability, but comes at the cost of some information loss. Our goal
in this section is to quantify this trade-off using cross-study validation. We
use the truncated Cτ statistic as proposed in Uno et al. (2011), truncated
at τ = 3 years, for measuring survival prediction accuracy. The Cτ statistic,
given a prediction model M and independent (possibly censored) survival
data with covariates (Yi,Xi), i= 1, . . . , n, from an unknown distribution P ,
estimates the conditional probability P (rn+1 ≥ rn+2|Yn+1 ≤ Yn+2, Yn+1 ≤ τ).
The random variables (rn+1, rn+2) are risk scores computed from M based
on individual covariates (Xn+1,Xn+2); if, for instance, M is a proportional
hazards model with coefficients βˆ, then rn+1 = βˆXn+1 and rn+2 = βˆXn+2.
The estimate converges, under the assumption of noninformative censoring,
to the unknown conditional probability. It is only required that the censoring
cumulative distribution function remains below 1 at τ .
We applied our method with prediction models constructed using several
approaches. The first one is a direct application of survival ridge regression,
using available gene expression data, under the assumption of proportional
hazards with a linear link function. The second is similar to the approach
followed in Kang, D’Andrea and Kozono (2012); we only use available gene
expression data within the selective list proposed by the authors. Note that
we do not attempt to reproduce their study; we follow a similar strategy.
Also, in this case prediction models were derived using penalized maximum
likelihood. Additionally, to these two approaches we also attempted the use
of Kernel-based methods for estimating a smooth nonparametric link func-
tion [Li and Luan (2003)]. This produced results (i.e., values of the Cτ
estimator) clearly inferior to the first two approaches.
Our goal is to show that the cross-study validation approach we present
here facilitates methods comparison by estimating the easily interpretable
µ latent variables. All the analyses were repeated separately under each
method. Modeling of the Z array, in this example, produces an appreciable
reduction of the uncertainty on the µ latent variables compared to the direct
computation of the credible intervals by bootstrapping. All the model-based
estimates of the µ latent variable are shrunk toward the average of the Z
entries.
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Fig. 3. Validation analysis based on Cτ statistics. The left panel considers ridge regres-
sion based on all available gene expression data, while the right panel considers only a list
of genes selected on the basis of the proposal in Kang, D’Andrea and Kozono (2012). Each
colored point illustrates a Z110s,v validation statistic; colors indicate the training data set s
while the integers in gray indicate the validation data set v. The “−” symbols indicate the
corresponding Bayesian estimates E(µ110C(s),C(v)|Z
110). The dashed lines are 80% confidence
intervals of the unknown means E(Z110s,v ) obtained by Bootstrapping. The “
∗” symbols in-
dicate 80% credible intervals obtained from the posterior distribution of µ110C(s),C(v) given
Z110.
Figure 3 shows the observed validation statistics Z110s,v . As mentioned,
these are empirical estimates of predictive performances adjusted for sam-
ple size variability. Each panel corresponds to one of the two approaches
we compare, and colors indicate the training data sets, while the integers
displayed in grey indicate the validation data sets. The plots show the 80%
confidence intervals of the unknown means E(Z110s,v ) obtained by bootstrap-
ping (dashed lines). They also display the model estimates (marked with
the “−” symbol) of the µ110C(s),C(v) variables and the 80% credible intervals
(marked with the “∗” symbol). Under both approaches all µ110C(s),C(v) variables
are estimated within the (0.5,0.6) interval. Our comparison suggests that
models fitted after upfront selection of a subset of genes based on biological
hypothesis perform worse than using all gene expression data. This indicates
that genes other than those involved directly in DNA damage repair can con-
tribute to explaining survival of ovarian cancer patients. All comparisons of
the Bayesian estimates E(µ110C(s),C(v)|Z110) under the two approaches are con-
sistent with this evaluation. We also compared the posterior distributions
20 TRIPPA, WALDRON, HUTTENHOWER AND PARMIGIANI
of µ110C(s),C(v) under the two approaches; at each pair (s, v), when we sample
from the posterior distributions we obtain inferior µ110C(s),C(v) values for the
selective approach with probability above 0.67. If we use all genes, we obtain
a probability of 0.78 that all µ110C(s),C(v) are larger than 0.5, meaning that all
models perform better than assigning risk scores completely at random.
The posterior distribution of the latent partition of the 6 studies with
sample sizes above 110 suggests the existence of two clusters, one includ-
ing studies 4 and 5 and the other with all remaining studies. The estimate
of the latent partition is identical under the two considered approaches for
constructing predictive models but needs to be combined with relevant un-
certainty. In particular, in both cases the partition constituted by a single
degenerate subset with the six studies together accumulates posterior prob-
abilities from both approaches above 0.15. When we added to the analysis
the remaining three studies with sample sizes below 110, the resulting prob-
abilities of the degenerate partition remained above 0.12. In summary, we
found moderate evidence of a nondegenerate partition with heterogeneous
subgroups.
In order to interpret the latent partition estimate of our leave-one-in anal-
ysis, we computed clustering-based validation statistics. Each solid line in
Figure 4 is representative of a data set s and illustrates, for hypothetical sam-
ple sizes j from 100 to 600, estimates of how well outcomes in study s can be
predicted by randomly selecting j data points within the cluster containing
s. More formally, the y axis shows estimates of ZjB(s),s with j = 100, . . . ,600.
In this example the reported probabilities of the events
∑
v∈B(s)\s nv ≥ j are
Fig. 4. Sample size adjusted validation statistics. Solid lines display estimates of the
clustering-based statistics Zj
B(s),s for values of j ranging between 100 and 600. Dashed
lines display the validation statistics Zj{1,...,S},s, that is, the cluster B(s) is replaced with
the entire collection of 9 studies. Each color corresponds to a specific validation study s.
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all above 0.6 for j ≤ 300. These estimates are contrasted (dashed lines in
Figure 4) with Zj{1,...,S},s. These are estimates of how well outcomes in s can
be predicted by randomly selecting j data points from all available studies.
We observe little difference between the solid and dashed lines. This similar-
ity suggests that the clustering is not driven by heterogeneous data quality
levels across studies (i.e., there is no evidence of clusters that produce pre-
diction models with poor performance). Clustering is driven by studies 4
and 5, in which, due to covariates distributions, it appears relatively easier
to achieve C-statistics above 0.6 compared to all other studies. Clustering-
based statistics in Figure 4 suggest additional samples, above 600 and above
the overall number of samples from the nine studies, might significantly con-
tribute obtaining better prediction models.
For a comparison, we fitted the data sets with a hierarchical propor-
tional hazards model, with studies clustered through a Dirichlet process,
and Normal marginal priors for the regression coefficients. The prior assigns
a vector of regression coefficients to each cluster of studies, while coefficients
are independent across clusters. To facilitate the comparison, we tuned the
Dirichlet process to match the estimate of the number of clusters in our
leave-one-in analysis. We used the list of possible values for the latent parti-
tion and approximated the posterior using the approach discussed in Sinha,
Ibrahim and Chen (2003). Our interest is in comparing the latent parti-
tions obtained using the model just described to those from the validation
analysis. If clustering in the leave-one-in analysis is driven by differences
in the study-specific regression models, and not in the distributions of the
predictors, then one expects the two approaches to infer similar partitions.
Instead, the total variation distance between posterior distributions is 0.79,
and we did not notice similarities. This is consistent with the interpretation
of the partition inferred through the validation analysis that we discussed
in the previous paragraph.
We also considered random survival forests for constructing prediction
models; we used methodology and software discussed in Ishwaran et al.
(2008). This method directly provides mortality scores for each sample in
a test data set. Under several choices of the tuning parameters involved in
the application of random forests, including minimal final nodes sizes [see
Ishwaran et al. (2008) for details], the resulting predictive models appeared
inferior to ridge regression when compared using Cτ statistics. Under all
considered choices of the tuning parameters at least 66% of the µ110C(s),C(v)
estimates were inferior to ridge regression. Contrasting results with random
survival forests based on all available gene expression data versus the use
of selected genes as suggested in Kang, D’Andrea and Kozono (2012), we
obtained again higher µ110C(s),C(v) estimates using all available gene expression
data.
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6. An example of heterogeneous studies. Next we discuss cross-study
validation of four nonsmall cell lung cancer studies recently reviewed in
Ferte´ et al. (2013), based on the data sets curated by the authors. The data
structure is similar to the previous example and includes gene expression
predictors and patient survival times. We refer to Ferte´ et al. (2013) for a
detailed description. The four studies and corresponding samples sizes are
as follows: the Director’s challenge study Shedden et al. (2008) (299), Zhu
et al. (2010) study (62), Hou et al. (2010) study (79) and the TCGA [Ham-
merman et al. (2012)] study (90). This example emphasizes the necessity
of accounting for study heterogeneity and that averaging the Zs,v statistics
does not provide a complete description of models’ performances.
The Director’s study [Shedden et al. (2008)] includes data from 4 insti-
tutions. Our first analysis investigates whether there are large differences
in the data originating from these institutions. The posterior of the model
assigns probability 0.83 to the event that these 4 data sets are clustered
together. Then, we considered the hypothesis of clusters involving the re-
maining data sets [Zhu et al. (2010), Hou et al. (2010), Hammerman et al.
(2012)]. The approach is identical to the description in the previous section:
we trained models using gene expression data and validated using concor-
dance Cτ statistics. The posterior of Π produced an estimate of two clusters,
one including the Director’s study and the Zhu et al. study, and the second
including the remaining two studies. The posterior strongly supports the
hypothesis of separate clusters. The posterior probability at the estimated
configuration Πˆ is 0.44, and 0.48 posterior probability accumulates on the
neighborhood {Π: l(Π, Πˆ) = 1}.
We finally compared sample size adjusted statistics Zjs,v to interpret the
clustering configuration. Figure 5 summarizes the main discrepancies visu-
alized with these comparisons. On average, models fitted with 50≤ j ≤ 290
samples from the Director’s study tend to achieve substantially higher vali-
dation results when validated on the Zhu et al. study (blue line) than when
validated on the remaining two studies (black lines). In the latter case the
validation statistics decrease with training data set sample size, and the fit-
ted models fail to predict survival times. We tested this difference using the
bootstrap covariance estimates. The evaluation of prediction models pro-
duced by the largest study [Shedden et al. (2008)] changes considerably if
we only average the validation statistics across the three remaining studies,
and it appears appropriate to report substantial discrepancies when we vali-
date the Director’s study results with the Zhu et al. study, versus validation
on the Hou et al. and TCGA studies. While this is beyond the scope of
our analysis, the next step is to investigate in depth the reason for these
discrepancies.
7. Discussion. Despite the availability of large collections of related data
sets in many areas of application, articles that evaluate statistical learning
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Fig. 5. Sample size adjusted validation statistics for interpreting the clustering estimate
Πˆ. The plot displays Zjs,v validation statistics when the model is trained by the largest
study [Shedden et al. (2008)] and validated on the remaining studies (black and blue lines).
Additionally, it displays validation statistics when we train on the Hou et al. study and
use the TCGA study for validation (green line). Prediction models have been trained using
ridge regression.
algorithms based on a comprehensive analysis of available data sets remain
a minority. Those using more than one data set are often based on cross-
validation within each study due to heterogeneity between studies; see Jap-
kowicz and Shah (2011), Demsˇar (2006) and Bernau et al. (2014) for discus-
sions. Similar to meta-analyses for evidence synthesis, comprehensive model
evaluations need to jointly consider study heterogeneity and algorithm per-
formance. Here we propose a Bayesian approach to compare algorithms while
incorporating relevant sources of uncertainty, including uncertainty on the
comparability of independent studies.
The basis for our framework is the leave-one-in array Z of validation
statistics. The concept is applicable to any validation statistic, such as con-
cordance indices, classification errors and distances between predicted and
observed responses. While it is certainly possible, and very useful, to simply
use the leave-one-in array as a visualization tool without further model-
ing, our experience with evaluating genomic signatures in cancer suggests
that modeling can substantially enhance interpretability of the leave-one-in
analysis. Modeling addresses study heterogeneity, can prevent erroneous in-
terpretations driven by sampling variability in the summary statistics, can
help address multiplicity issues, and can formalize the process of identifying
outlying studies requiring separate consideration. The analysis of the Z ar-
ray helps interpreting the range of observed cross-study validation statistics,
whether it is caused by differences in the study-specific distributions Ps or
it reflects sampling variability.
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Our two-stage procedure is based on a single figure of merit Z: this choice
is motivated by the need for a simple strategy and by the consideration that
this still accomplishes the main goal to control sources of overoptimism such
as over-fitting, selection of favorable training/testing combinations and the
use of internal cross-validations when the studies at hand are heterogeneous.
Use of a one-dimensional figure of merit can, however, be a limitation. For
example, if two studies generated data of poor quality, perhaps because of
errors during sample processing and data management, our algorithm would
likely cluster them together, because they both fail to produce accurate
predictions and generate similarly poor Z scores when used for validating
candidate models. These two studies might still be different in important
ways; for example, they may consider two different populations. From this
perspective, additional summaries of the data and potentially additional
analyses may be advisable to identify differences between studies.
When multiple studies are available, a natural direction is to combine
them. Bayesian hierarchical models, for instance, have emerged as a very
useful paradigm to borrow information across studies [Lindley and Smith
(1972) and Morris and Normand (1992)]. The leave-one-in analysis is not
intended to replace combined analyses, but to address a different question:
cross-study replicability of prediction. We consider the evaluation of predic-
tion methods using leave-one-in matrices an important complementary goal
and, in some cases, a prerequisite to the construction of predictive models
based on multiple data sources. The analysis of leave-one-in matrices can be
used not only to compare prediction methods, but also to select the most
appropriate prediction methods for a subsequent combined analysis. In a re-
lated application to ovarian cancer prognosis using gene expression profiles,
we illustrate a case where we first use cross-study validation to quantify the
extent to which existing prognostic algorithms can produce results that hold
up across studies [Waldron et al. (2014)], and then proceed to develop new
prognostic algorithms based on a combined analysis [Riester et al. (2014)].
One advantage of the leave-one-in approach is that it can be used to
evaluate any prediction approach, including heuristic procedures for which
it might be challenging to construct hierarchical extensions. The modeling
complexity that comes with constructing joint models for multiple studies
varies across fields. In some cases the algorithms are based on probabilistic
models and multi-study extensions are possible. In others they are not, and
might be based on heuristics or be very specific to the field of application.
The complexity and problem-specific competence necessary for developing
joint models for heterogeneous data sets are greater compared to the analysis
of Z matrices for off-the-shelf methods.
To address study heterogeneity, we cluster studies with similar validation
profiles through a latent partition. The computation of the posterior distri-
bution of the latent partition is straightforward and is a direct application
of established computational strategies for fitting Dirichlet mixture mod-
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els. We refer to the supplementary material [Trippa et al. (2015)] for more
details. Clustering sharpens the interpretation of the cross-study validation
results by allowing one to explore the maps B→ ZB,s, focusing on either
the estimates Bˆ(s) or on those partitions that a posteriori appear consistent
with the dispersion estimate dˆ and the observed array Z.
A simple alternative to formal Bayesian clustering of data sets is a re-
ordering of rows and columns of Z, by maximizing objective functions, to
obtain high values of the validation statistics close to the matrix diagonal.
While this is perhaps simpler than what we propose, it can be dangerous to
interpret the Zs,v validation summaries without consideration of the associ-
ated sampling variability, and it is easy to introduce an optimistic bias with
clusters obtained by optimizing intra-cluster validation statistics.
In this article we only considered external validation statistics, where
training and testing are performed on separate studies. Alternatively, one
could integrate internal cross-validation into our framework by adding a di-
agonal to the Z array, with entries consisting of within study cross-validation
statistics. A drawback of standard cross-validation techniques in this con-
text is that they may result in overly optimistic assessments [Bernau et al.
(2014)].
In this work we compared learning algorithms by separate analyses of the
resulting Z arrays, but a natural extension is the joint analysis of multiple Z
arrays corresponding to competing algorithms. A similar discussion applies
to consideration of multiple validation statistics at the same time. A separate
refinement could seek a data-driven approach for selecting the thresholds
described in Section 5.1 to correct for sample size differences across studies.
SUPPLEMENTARY MATERIAL
Supplement to “Bayesian nonparametric cross-study validation of predic-
tion methods” (DOI: 10.1214/14-AOAS798SUPP; .pdf). We discuss results
for logistic regression, Poisson regression, proportional hazards models and
support vector machine procedures in the supplementary material.
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